“…Series of patients reporting clinical data and molecular studies followed with a mutation detection rate of about 50% overall and up to 90% in familial cases [Ross et al, 1998;Belloni et al, 2000;Hagan et al, 2000;Kochling et al, 2001;Martucciello et al, 2004;Urioste et al, 2004;Garcia-Barcelo et al, 2006;Wang et al, 2006;Liang et al, 2007;Volk et al, 2007]. A broad inter-and intrafamilial phenotypic variability is observed [Ross et al, 1998;Belloni et al, 2000;Hagan et al, 2000;Kochling et al, 2001] that accounts for late-onset CS or even undiagnosed cases.…”